// App-Quantinova.ai

P990 : Treatment of COVID-19 Pneumonia and Acute Respiratory Distress with Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A 4-Patient Case Series Report

Researchers

Presenter

  • M. L. Ogletree

Principal Investigators

  • R. Kulshreshta

  • A. Agarwal

  • K. C. Chiang

  • A. Gupta

Medical Centers

  • Pharmacology, Vanderbilt University, Nashville, TN, United States

  • EyeSight Eye Hospital and Retina Centre, Madhya Pradesh, India

  • Medicine, University of California Irvine, Orange, CA, United States

  • Regulatory Wisdom, Delhi, India

  • KARE Biosciences, Orange, CA, United States

Locations

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Severe COVID-19 pneumonia

  • Allergic rhinitis

  • Acute lung injury

  • Pulmonary edema

  • Venous thrombosis

  • Pneumonia

  • Coronavirus disease

Biomarkers

  • Prostaglandin D2

Drug/Treatment

  • IFN-lambda

  • Dinoprostone

  • Prostaglandin

  • Ramatroban

  • Interferon

  • Lanthanum carbonate

Outcome

  • N/A

Study Design

  • Case series

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved